Axsome Therapeutics Inc (AXSM): Next-Year EPS Estimate 373.97%
As of 2026-06-18, Axsome Therapeutics Inc (AXSM) has a next-year EPS growth estimate of 373.97%. Featured in our EPS revision report on 2026-05-04.
On 2026-06-17, analyst consensus for AXSM's next-year EPS growth shifted from 381.48% to 373.97% — a negative change of 7.51 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at 45.44%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 373.97%
- EPS growth this year
- 45.44%
- EPS next quarter (est)
- -$0.85
- Last price
- $250.50
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-18 | 373.97% | 45.44% | -$0.85 | $250.50 |
| 2026-06-17 | 373.97% | 45.44% | -$0.85 | $252.16 |
| 2026-06-16 | 381.48% | 46.68% | -$0.84 | $251.91 |
| 2026-06-15 | 381.48% | 46.68% | -$0.84 | $253.40 |
| 2026-06-14 | 381.48% | 46.68% | -$0.84 | $255.17 |
| 2026-06-11 | 382.85% | 46.46% | -$0.84 | $253.77 |
| 2026-06-10 | 381.48% | 46.68% | -$0.84 | $246.34 |
| 2026-06-09 | 381.48% | 46.68% | -$0.84 | $245.64 |
| 2026-06-08 | 381.48% | 46.68% | -$0.84 | $235.14 |
| 2026-06-07 | 381.48% | 46.68% | -$0.84 | $232.32 |
| 2026-06-04 | 381.48% | 46.68% | -$0.84 | $231.48 |
| 2026-06-03 | 381.48% | 46.68% | -$0.84 | $233.49 |
| 2026-06-02 | 381.49% | 46.68% | -$0.84 | $222.16 |
| 2026-06-01 | 381.49% | 46.68% | -$0.84 | $230.25 |
| 2026-05-31 | 394.48% | 46.68% | -$0.84 | $234.48 |
| 2026-05-28 | 394.48% | 46.68% | -$0.84 | $232.83 |
| 2026-05-27 | 394.48% | 46.68% | -$0.84 | $234.52 |
| 2026-05-26 | 394.56% | 46.68% | -$0.84 | $234.20 |
| 2026-05-25 | 394.56% | 46.68% | -$0.84 | $235.97 |
| 2026-05-24 | 394.56% | 46.68% | -$0.84 | $235.97 |
| 2026-05-21 | 394.56% | 46.68% | -$0.84 | $233.64 |
| 2026-05-20 | 394.56% | 46.68% | -$0.84 | $230.62 |
| 2026-05-19 | 394.56% | 46.68% | -$0.84 | $226.67 |
| 2026-05-18 | 394.56% | 46.68% | -$0.84 | $227.40 |
| 2026-05-17 | 394.56% | 46.68% | -$0.84 | $227.72 |
| 2026-05-14 | 394.56% | 46.68% | -$0.84 | $232.27 |
| 2026-05-13 | 394.56% | 46.68% | -$0.84 | $233.98 |
| 2026-05-12 | 394.56% | 46.68% | -$0.84 | $224.03 |
| 2026-05-11 | 394.56% | 46.68% | -$0.84 | $216.47 |
| 2026-05-10 | 394.56% | 46.68% | -$0.84 | $217.38 |
Reports Featuring AXSM
Recent News
- Axsome Therapeutics, Inc. Q1 2026 Earnings Call SummaryMoby
- Axsome: Q1 Earnings SnapshotAssociated Press
- Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business UpdateGlobeNewswire
- Summits self-inflicted stumble; Esperions take-private dealBioPharma Dive
- Summits self-inflicted stumble; Esperions take-private dealBioPharma Dive
- Axsome Therapeutics Hosts AUVELITY FDA Approval Investor Event Featuring Expert Thought LeaderGlobeNewswire
- Axsome Therapeutics Hosts AUVELITY FDA Approval Investor Event Featuring Expert Thought LeaderGlobeNewswire
- Axsome Therapeutics Announces FDA Approval of AUVELITY (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer's DiseaseGlobeNewswire
- Biotech Stock Knocks At $2 Billion Opportunity, Nears Buy PointInvestor's Business Daily
Screen Performance
Aggregate stats across all 1795 tickers our top-EPS-revision screen has flagged over the past 78 days.
- Median return since detection
- +3.6%
- % of tickers in the green
- 58%
- Median return on winners
- +19.9%
- Large revisions captured
- 842
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Axsome Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-18, Axsome Therapeutics Inc (AXSM) has a next-year EPS growth estimate of 373.97%, based on analyst consensus.
When was the latest EPS estimate revision for AXSM?▾
The most recent revision occurred on 2026-06-17, when analysts adjusted the next-year EPS growth estimate from 381.48% to 373.97%.
What sector and industry does Axsome Therapeutics Inc belong to?▾
Axsome Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AXSM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Axsome Therapeutics Inc (AXSM) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports